Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pigeon Corporation (PGENY) Fair Value & Analysis

Consumer Defensive · US · Market cap $1.5B

Price$3.10
Fair Value$2.72
Upside-12.3%
Quality91/100
Evidence: High Range $1.98 – $3.41

Analysis

Pigeon Corporation (PGENY) currently trades at $3.10, while our model-based Fair Value estimate is $2.72 — implying the stock looks roughly 12.3% overvalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Pigeon Corporation, together with its subsidiaries, engages in the manufacture, sale, import, and export of baby and child-care products, maternity items, women's care products, home healthcare products, and nursing care products in Japan and internationally. The company operates through four segments: Japan Business, China Business, Singapore Business, and Lansinoh Business. The company is also involved in the provision of baby and mother care products, such as nursing bottles and nipples, toiletries, breast pads, breast pumps, nipple care products, nipple care cream, breast milk storage bags, and breastfeeding-related products under Pigeon and Lansinoh brands. It also offers non-woven products, baby strollers, aging-prevention products, wet wipes, high-end skincare products, cleaning and disinfecting products, child-rearing support, healthcare, and elder care products and services. In addition, the company provides child-minding and daycare services, toiletries, home nursing care …

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.